<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2017-05-10" version="224">
<accession>P04629</accession>
<accession>B2R6T5</accession>
<accession>B7ZM34</accession>
<accession>P08119</accession>
<accession>Q15655</accession>
<accession>Q15656</accession>
<accession>Q5D056</accession>
<accession>Q5VZS2</accession>
<accession>Q7Z5C3</accession>
<accession>Q9UIU7</accession>
<name>NTRK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>High affinity nerve growth factor receptor</fullName>
<ecNumber evidence="34 46">2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Neurotrophic tyrosine kinase receptor type 1</fullName>
</alternativeName>
<alternativeName>
<fullName>TRK1-transforming tyrosine kinase protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Tropomyosin-related kinase A</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase receptor A</fullName>
<shortName>Trk-A</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="54">gp140trk</fullName>
</alternativeName>
<alternativeName>
<fullName>p140-TrkA</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NTRK1</name>
<name type="synonym">MTC</name>
<name type="synonym" evidence="54">TRK</name>
<name type="synonym" evidence="55">TRKA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Mol. Cell. Biol." volume="9" first="24" last="33">
<title>Molecular and biochemical characterization of the human trk proto-oncogene.</title>
<authorList>
<person name="Martin-Zanca D."/>
<person name="Oskam R."/>
<person name="Mitra G."/>
<person name="Copeland T.D."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="2927393"/>
<dbReference type="DOI" id="10.1128/MCB.9.1.24"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKA-I)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="J. Neurosci." volume="15" first="477" last="491">
<title>Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins.</title>
<authorList>
<person name="Shelton D.L."/>
<person name="Sutherland J."/>
<person name="Gripp J."/>
<person name="Camerato T."/>
<person name="Armanini M.P."/>
<person name="Phillips H.S."/>
<person name="Carroll K."/>
<person name="Spencer S.D."/>
<person name="Levinson A.D."/>
</authorList>
<dbReference type="PubMed" id="7823156"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Jpn. J. Hum. Genet." volume="42" first="343" last="351">
<title>Structure and organization of the human TRKA gene encoding a high affinity receptor for nerve growth factor.</title>
<authorList>
<person name="Indo Y."/>
<person name="Mardy S."/>
<person name="Tsuruta M."/>
<person name="Karim M.A."/>
<person name="Matsuda I."/>
</authorList>
<dbReference type="PubMed" id="9290260"/>
<dbReference type="DOI" id="10.1007/BF02766957"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TRKA-II)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-175 (ISOFORM 3)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS TRKA-I AND TRKA-II)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="5108" last="5118">
<title>Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression.</title>
<authorList>
<person name="Fujimoto M."/>
<person name="Kitazawa R."/>
<person name="Maeda S."/>
<person name="Kitazawa S."/>
</authorList>
<dbReference type="PubMed" id="15870692"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208697"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1986" name="Nature" volume="319" first="743" last="748">
<title>A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.</title>
<authorList>
<person name="Martin-Zanca D."/>
<person name="Hughes S.H."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="2869410"/>
<dbReference type="DOI" id="10.1038/319743a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 399-796</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH TPM3</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1988" name="EMBO J." volume="7" first="147" last="154">
<title>Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.</title>
<authorList>
<person name="Kozma S.C."/>
<person name="Redmond S.M.S."/>
<person name="Saurer S.M."/>
<person name="Groner B."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="2966065"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 399-796</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="6118" last="6127">
<title>The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.</title>
<authorList>
<person name="Greco A."/>
<person name="Mariani C."/>
<person name="Miranda C."/>
<person name="Lupas A."/>
<person name="Pagliardini S."/>
<person name="Pomati M."/>
<person name="Pierotti M.A."/>
</authorList>
<dbReference type="PubMed" id="7565764"/>
<dbReference type="DOI" id="10.1128/MCB.15.11.6118"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 399-796</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH TFG</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1992" name="Oncogene" volume="7" first="237" last="242">
<title>TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.</title>
<authorList>
<person name="Greco A."/>
<person name="Pierotti M.A."/>
<person name="Bongarzone I."/>
<person name="Pagliardini S."/>
<person name="Lanzi C."/>
<person name="Della Porta G."/>
</authorList>
<dbReference type="PubMed" id="1532241"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 486-796</scope>
<scope>CHROMOSOMAL REARRANGEMENT WITH TPR</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="Nature" volume="350" first="678" last="683">
<title>High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor.</title>
<authorList>
<person name="Hempstead B.L."/>
<person name="Martin-Zanca D."/>
<person name="Kaplan D.R."/>
<person name="Parada L.F."/>
<person name="Chao M.V."/>
</authorList>
<dbReference type="PubMed" id="1850821"/>
<dbReference type="DOI" id="10.1038/350678a0"/>
</citation>
<scope>FUNCTION AS RECEPTOR FOR NGF</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="Cell" volume="65" first="189" last="197">
<title>The trk proto-oncogene encodes a receptor for nerve growth factor.</title>
<authorList>
<person name="Klein R."/>
<person name="Jing S."/>
<person name="Nanduri V."/>
<person name="O'Rourke E."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="1849459"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90419-Y"/>
</citation>
<scope>FUNCTION IN NGF SIGNALING</scope>
<scope>IDENTIFICATION AS THE HIGH AFFINITY NGF RECEPTOR</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1992" name="Neuron" volume="9" first="1067" last="1079">
<title>Nerve growth factor mediates signal transduction through trk homodimer receptors.</title>
<authorList>
<person name="Jing S."/>
<person name="Tapley P."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="1281417"/>
<dbReference type="DOI" id="10.1016/0896-6273(92)90066-M"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-544</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="15150" last="15157">
<title>Tissue-specific alternative splicing generates two isoforms of the trkA receptor.</title>
<authorList>
<person name="Barker P.A."/>
<person name="Lomen-Hoerth C."/>
<person name="Gensch E.M."/>
<person name="Meakin S.O."/>
<person name="Glass D.J."/>
<person name="Shooter E.M."/>
</authorList>
<dbReference type="PubMed" id="8325889"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS TRKA-I AND TRKA-II)</scope>
<scope>FUNCTION IN CELL SURVIVAL</scope>
<scope>NGF-BINDING</scope>
<scope>PHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="8901" last="8910">
<title>A Trk nerve growth factor (NGF) receptor point mutation affecting interaction with phospholipase C-gamma 1 abolishes NGF-promoted peripherin induction but not neurite outgrowth.</title>
<authorList>
<person name="Loeb D.M."/>
<person name="Stephens R.M."/>
<person name="Copeland T.D."/>
<person name="Kaplan D.R."/>
<person name="Greene L.A."/>
</authorList>
<dbReference type="PubMed" id="7510697"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-791</scope>
<scope>INTERACTION WITH PLCG1</scope>
<scope>MUTAGENESIS OF TYR-791</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1994" name="Neuron" volume="12" first="691" last="705">
<title>Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses.</title>
<authorList>
<person name="Stephens R.M."/>
<person name="Loeb D.M."/>
<person name="Copeland T.D."/>
<person name="Pawson T."/>
<person name="Greene L.A."/>
<person name="Kaplan D.R."/>
</authorList>
<dbReference type="PubMed" id="8155326"/>
<dbReference type="DOI" id="10.1016/0896-6273(94)90223-2"/>
</citation>
<scope>FUNCTION IN NEURONAL DIFFERENTIATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF SHC1 AND PLCG1</scope>
<scope>INTERACTION WITH SHC1</scope>
<scope>MUTAGENESIS OF TYR-496; LYS-544 AND TYR-791</scope>
<scope>PHOSPHORYLATION AT TYR-496 AND TYR-791</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="7709" last="7712">
<title>The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor.</title>
<authorList>
<person name="Wooten M.W."/>
<person name="Seibenhener M.L."/>
<person name="Mamidipudi V."/>
<person name="Diaz-Meco M.T."/>
<person name="Barker P.A."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="11244088"/>
<dbReference type="DOI" id="10.1074/jbc.C000869200"/>
</citation>
<scope>FUNCTION IN NF-KAPPA-B ACTIVATION</scope>
<scope>INTERACTION WITH SQSTM1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Cancer Cell" volume="6" first="347" last="360">
<title>TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.</title>
<authorList>
<person name="Tacconelli A."/>
<person name="Farina A.R."/>
<person name="Cappabianca L."/>
<person name="Desantis G."/>
<person name="Tessitore A."/>
<person name="Vetuschi A."/>
<person name="Sferra R."/>
<person name="Rucci N."/>
<person name="Argenti B."/>
<person name="Screpanti I."/>
<person name="Gulino A."/>
<person name="Mackay A.R."/>
</authorList>
<dbReference type="PubMed" id="15488758"/>
<dbReference type="DOI" id="10.1016/j.ccr.2004.09.011"/>
</citation>
<scope>FUNCTION IN NEURONAL CELL PROLIFERATION AND DIFFERENTIATION</scope>
<scope>FUNCTION IN SIGNALING CASCADE ACTIVATION</scope>
<scope>NGF-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM TRKA-III)</scope>
<scope>CHARACTERIZATION OF ISOFORM TRKA-III</scope>
<scope>PHOSPHORYLATION AT TYR-496; TYR-680; TYR-681 AND TYR-791</scope>
<scope>INTERACTION WITH FRS2; GRB2; PIK3R1; PLCG1; SHC1</scope>
<scope>GLYCOSYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY HYPOXIA</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Nat. Neurosci." volume="14" first="54" last="61">
<title>Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling.</title>
<authorList>
<person name="Vaegter C.B."/>
<person name="Jansen P."/>
<person name="Fjorback A.W."/>
<person name="Glerup S."/>
<person name="Skeldal S."/>
<person name="Kjolby M."/>
<person name="Richner M."/>
<person name="Erdmann B."/>
<person name="Nyengaard J.R."/>
<person name="Tessarollo L."/>
<person name="Lewin G.R."/>
<person name="Willnow T.E."/>
<person name="Chao M.V."/>
<person name="Nykjaer A."/>
</authorList>
<dbReference type="PubMed" id="21102451"/>
<dbReference type="DOI" id="10.1038/nn.2689"/>
</citation>
<scope>INTERACTION WITH SORT1</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1995" name="Nature" volume="378" first="584" last="592">
<title>Structure and ligand recognition of the phosphotyrosine binding domain of Shc.</title>
<authorList>
<person name="Zhou M.-M."/>
<person name="Ravichandran K.S."/>
<person name="Olejniczak E.F."/>
<person name="Petros A.M."/>
<person name="Meadows R.P."/>
<person name="Sattler M."/>
<person name="Harlan J.E."/>
<person name="Wade W.S."/>
<person name="Burakoff S.J."/>
<person name="Fesik S.W."/>
</authorList>
<dbReference type="PubMed" id="8524391"/>
<dbReference type="DOI" id="10.1038/378584a0"/>
</citation>
<scope>STRUCTURE BY NMR OF 489-500</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1999" name="J. Mol. Biol." volume="290" first="149" last="159">
<title>Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.</title>
<authorList>
<person name="Ultsch M.H."/>
<person name="Wiesmann C."/>
<person name="Simmons L.C."/>
<person name="Henrich J."/>
<person name="Yang M."/>
<person name="Reilly D."/>
<person name="Bass S.H."/>
<person name="de Vos A.M."/>
</authorList>
<dbReference type="PubMed" id="10388563"/>
<dbReference type="DOI" id="10.1006/jmbi.1999.2816"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 278-386</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1999" name="Nature" volume="401" first="184" last="188">
<title>Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.</title>
<authorList>
<person name="Wiesmann C."/>
<person name="Ultsch M.H."/>
<person name="Bass S.H."/>
<person name="de Vos A.M."/>
</authorList>
<dbReference type="PubMed" id="10490030"/>
<dbReference type="DOI" id="10.1038/43705"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 282-382 IN COMPLEX WITH NGF</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Neuron" volume="53" first="25" last="38">
<title>Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.</title>
<authorList>
<person name="Wehrman T."/>
<person name="He X."/>
<person name="Raab B."/>
<person name="Dukipatti A."/>
<person name="Blau H."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="17196528"/>
<dbReference type="DOI" id="10.1016/j.neuron.2006.09.034"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 36-382 IN COMPLEX WITH NGF</scope>
<scope>HOMODIMERIZATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-95; ASN-121; ASN-188; ASN-262; ASN-281 AND ASN-358</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="485" last="488">
<title>Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis.</title>
<authorList>
<person name="Indo Y."/>
<person name="Tsuruta M."/>
<person name="Hayashida Y."/>
<person name="Karim M.A."/>
<person name="Ohta K."/>
<person name="Kawano T."/>
<person name="Mitsubuchi H."/>
<person name="Tonoki H."/>
<person name="Awaya Y."/>
<person name="Matsuda I."/>
</authorList>
<dbReference type="PubMed" id="8696348"/>
<dbReference type="DOI" id="10.1038/ng0896-485"/>
</citation>
<scope>VARIANT CIPA ARG-577</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="1207" last="1210">
<title>A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis.</title>
<authorList>
<person name="Greco A."/>
<person name="Villa R."/>
<person name="Tubino B."/>
<person name="Romano L."/>
<person name="Penso D."/>
<person name="Pierotti M.A."/>
</authorList>
<dbReference type="PubMed" id="10090906"/>
<dbReference type="DOI" id="10.1086/302319"/>
</citation>
<scope>VARIANT CIPA PRO-780</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="1570" last="1579">
<title>Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor.</title>
<authorList>
<person name="Mardy S."/>
<person name="Miura Y."/>
<person name="Endo F."/>
<person name="Matsuda I."/>
<person name="Sztriha L."/>
<person name="Frossard P."/>
<person name="Moosa A."/>
<person name="Ismail E.A.R."/>
<person name="Macaya A."/>
<person name="Andria G."/>
<person name="Toscano E."/>
<person name="Gibson W."/>
<person name="Graham G.E."/>
<person name="Indo Y."/>
</authorList>
<dbReference type="PubMed" id="10330344"/>
<dbReference type="DOI" id="10.1086/302422"/>
</citation>
<scope>VARIANTS CIPA PRO-213; TRP-649 AND SER-714</scope>
<scope>VARIANTS SER-85; TYR-604 AND VAL-613</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="2784" last="2787">
<title>Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma.</title>
<authorList>
<person name="Gimm O."/>
<person name="Greco A."/>
<person name="Hoang-Vu C."/>
<person name="Dralle H."/>
<person name="Pierotti M.A."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="10443680"/>
<dbReference type="DOI" id="10.1210/jcem.84.8.5901"/>
</citation>
<scope>VARIANTS TYR-604; VAL-613 AND GLN-780</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1999" name="J. Invest. Dermatol." volume="112" first="810" last="814">
<title>A novel point mutation affecting the tyrosine kinase domain of the TRKA gene in a family with congenital insensitivity to pain with anhidrosis.</title>
<authorList>
<person name="Yotsumoto S."/>
<person name="Setoyama M."/>
<person name="Hozumi H."/>
<person name="Mizoguchi S."/>
<person name="Fukumaru S."/>
<person name="Kobayashi K."/>
<person name="Saheki T."/>
<person name="Kanzaki T."/>
</authorList>
<dbReference type="PubMed" id="10233776"/>
<dbReference type="DOI" id="10.1046/j.1523-1747.1999.00569.x"/>
</citation>
<scope>VARIANT CIPA VAL-587</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="231" last="238">
<title>Characterization of single-nucleotide polymorphisms in coding regions of human genes.</title>
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="10391209"/>
<dbReference type="DOI" id="10.1038/10290"/>
</citation>
<scope>VARIANTS TYR-604 AND VAL-613</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="373" last="373">
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="Am. J. Med. Genet." volume="92" first="353" last="360">
<title>Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF receptor gene, clinical findings, and results of nerve conduction studies.</title>
<authorList>
<person name="Shatzky S."/>
<person name="Moses S."/>
<person name="Levy J."/>
<person name="Pinsk V."/>
<person name="Hershkovitz E."/>
<person name="Herzog L."/>
<person name="Shorer Z."/>
<person name="Luder A."/>
<person name="Parvari R."/>
</authorList>
<dbReference type="PubMed" id="10861667"/>
<dbReference type="DOI" id="10.1002/1096-8628(20000619)92:5&lt;353::AID-AJMG12>3.0.CO;2-C"/>
</citation>
<scope>VARIANT CIPA LEU-695</scope>
<scope>VARIANT VAL-613</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2000" name="Hum. Genet." volume="106" first="116" last="124">
<title>Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families.</title>
<authorList>
<person name="Miura Y."/>
<person name="Mardy S."/>
<person name="Awaya Y."/>
<person name="Nihei K."/>
<person name="Endo F."/>
<person name="Matsuda I."/>
<person name="Indo Y."/>
</authorList>
<dbReference type="PubMed" id="10982191"/>
<dbReference type="DOI" id="10.1007/s004390051018"/>
</citation>
<scope>VARIANTS CIPA PRO-93; ARG-522; ARG-577; CYS-654 AND TYR-674</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2000" name="J. Cell. Physiol." volume="182" first="127" last="133">
<title>The Gly571Arg mutation, associated with the autonomic and sensory disorder congenital insensitivity to pain with anhidrosis, causes the inactivation of the NTRK1/nerve growth factor receptor.</title>
<authorList>
<person name="Greco A."/>
<person name="Villa R."/>
<person name="Fusetti L."/>
<person name="Orlandi R."/>
<person name="Pierotti M.A."/>
</authorList>
<dbReference type="PubMed" id="10567924"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-4652(200001)182:1&lt;127::AID-JCP14>3.0.CO;2-0"/>
</citation>
<scope>VARIANT CIPA ARG-577</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2001" name="Ann. Neurol." volume="49" first="521" last="525">
<title>A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V.</title>
<authorList>
<person name="Houlden H."/>
<person name="King R.H."/>
<person name="Hashemi-Nejad A."/>
<person name="Wood N.W."/>
<person name="Mathias C.J."/>
<person name="Reilly M."/>
<person name="Thomas P.K."/>
</authorList>
<dbReference type="PubMed" id="11310631"/>
<dbReference type="DOI" id="10.1002/ana.103"/>
</citation>
<scope>VARIANT CIPA CYS-359</scope>
<scope>VARIANTS TYR-604 AND VAL-613</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="179" last="188">
<title>Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor.</title>
<authorList>
<person name="Mardy S."/>
<person name="Miura Y."/>
<person name="Endo F."/>
<person name="Matsuda I."/>
<person name="Indo Y."/>
</authorList>
<dbReference type="PubMed" id="11159935"/>
<dbReference type="DOI" id="10.1093/hmg/10.3.179"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CIPA PRO-93; PRO-213; ARG-522; ARG-577; TRP-649; CYS-654 AND SER-714</scope>
<scope>CHARACTERIZATION OF VARIANTS SER-85; TYR-604; VAL-613 AND TYR-674</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ARG-80; VAL-107; MET-237; GLY-238; GLY-260; GLN-444; CYS-452; THR-566; TYR-604; VAL-613; GLN-780 AND ILE-790</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Neuromuscul. Disord." volume="18" first="159" last="166">
<title>Novel missense, insertion and deletion mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with congenital insensitivity to pain with anhidrosis.</title>
<authorList>
<person name="Huehne K."/>
<person name="Zweier C."/>
<person name="Raab K."/>
<person name="Odent S."/>
<person name="Bonnaure-Mallet M."/>
<person name="Sixou J.L."/>
<person name="Landrieu P."/>
<person name="Goizet C."/>
<person name="Sarlangue J."/>
<person name="Baumann M."/>
<person name="Eggermann T."/>
<person name="Rauch A."/>
<person name="Ruppert S."/>
<person name="Stettner G.M."/>
<person name="Rautenstrauss B."/>
</authorList>
<dbReference type="PubMed" id="18077166"/>
<dbReference type="DOI" id="10.1016/j.nmd.2007.10.005"/>
</citation>
<scope>VARIANTS CIPA SER-572 AND ARG-717</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="J. Neurol." volume="259" first="1673" last="1685">
<title>Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.</title>
<authorList>
<person name="Davidson G.L."/>
<person name="Murphy S.M."/>
<person name="Polke J.M."/>
<person name="Laura M."/>
<person name="Salih M.A."/>
<person name="Muntoni F."/>
<person name="Blake J."/>
<person name="Brandner S."/>
<person name="Davies N."/>
<person name="Horvath R."/>
<person name="Price S."/>
<person name="Donaghy M."/>
<person name="Roberts M."/>
<person name="Foulds N."/>
<person name="Ramdharry G."/>
<person name="Soler D."/>
<person name="Lunn M.P."/>
<person name="Manji H."/>
<person name="Davis M.B."/>
<person name="Houlden H."/>
<person name="Reilly M.M."/>
</authorList>
<dbReference type="PubMed" id="22302274"/>
<dbReference type="DOI" id="10.1007/s00415-011-6397-y"/>
</citation>
<scope>VARIANTS CIPA LYS-492 AND CYS-654</scope>
<scope>VARIANT TRP-6</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="55" last="63">
<title>A comprehensive functional analysis of NTRK1 missense mutations causing hereditary sensory and autonomic neuropathy type IV (HSAN IV).</title>
<authorList>
<person name="Shaikh S.S."/>
<person name="Chen Y.C."/>
<person name="Halsall S.A."/>
<person name="Nahorski M.S."/>
<person name="Omoto K."/>
<person name="Young G.T."/>
<person name="Phelan A."/>
<person name="Woods C.G."/>
</authorList>
<dbReference type="PubMed" id="27676246"/>
<dbReference type="DOI" id="10.1002/humu.23123"/>
</citation>
<scope>VARIANTS CIPA GLU-517; GLU-522; PRO-657; THR-699; SER-752; SER-763 AND CYS-771</scope>
<scope>CHARACTERIZATION OF VARIANTS CIPA GLU-517; GLU-522; PRO-657; THR-699; SER-752; SER-763 AND CYS-771</scope>
<scope>GLYCOSYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION AFTER NGF STIMULATION</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="16 17 32 34 36 37 40 41 44 49 50">Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand (PubMed:1850821, PubMed:1849459, PubMed:1281417, PubMed:8325889, PubMed:15488758, PubMed:17196528). Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation (PubMed:1281417). Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors.</text>
</comment>
<comment type="function">
<text evidence="36">Isoform TrkA-III: Resistant to NGF, it constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed.</text>
</comment>
<comment type="catalytic activity">
<text evidence="21 34 46">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="15 17">The pro-survival signaling effect of NTRK1 in neurons requires its endocytosis into signaling early endosomes and its retrograde axonal transport. This is regulated by different proteins including CFL1, RAC1 and SORT1. NTF3 is unable to induce this signaling probably due to the lability of the NTF3-NTRK1 complex in endosomes. SH2D1A inhibits the autophosphorylation of the receptor, and alters the recruitment and activation of downstream effectors and signaling cascades (By similarity). Regulated by NGFR (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="15 16 27 32 34 36 37 42 47 49 50">Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Homodimerization is induced by binding of a NGF dimer (PubMed:1281417, PubMed:10490030, PubMed:17196528). Interacts with SQSTM1; bridges NTRK1 to NGFR (PubMed:11244088). Forms a ternary complex with NGFR and KIDINS220; this complex is affected by the expression levels of KIDINS220 and an increase in KIDINS220 expression leads to a decreased association of NGFR and NTRK1 (By similarity). Interacts with SH2D1A; regulates NTRK1 (By similarity). Interacts (phosphorylated upon activation by NGF) with SHC1; mediates SHC1 phosphorylation and activation (PubMed:8155326, PubMed:15488758). Interacts (phosphorylated upon activation by NGF) with PLCG1; mediates PLCG1 phosphorylation and activation (PubMed:7510697, PubMed:15488758). Interacts (phosphorylated) with SH2B1 and SH2B2 (By similarity). Interacts with GRB2 (PubMed:15488758). Interacts with PIK3R1 (PubMed:15488758). Interacts with FRS2 (PubMed:15488758). Interacts with SORT1; may regulate NTRK1 anterograde axonal transport (PubMed:21102451). Interacts with RAB7A (By similarity). Found in a complex, at least composed of KIDINS220, MAGI2, NTRK1 and RAPGEF2; the complex is mainly formed at late endosomes in a nerve growth factor (NGF)-dependent manner (By similarity). Interacts with RAPGEF2; the interaction is strengthened after NGF stimulation (By similarity). Interacts with PTPRS (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028226"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028226"/>
<interactant intactId="EBI-1028250">
<id>P01138</id>
<label>NGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028226"/>
<interactant intactId="EBI-8602514">
<id>Q8K4V6</id>
<label>Pirb</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028226"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1028226"/>
<interactant intactId="EBI-1057058">
<id>Q99523</id>
<label>SORT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="34 36 37 44 46">Cell membrane</location>
<topology evidence="34 36">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Early endosome membrane</location>
<topology evidence="16">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Late endosome membrane</location>
<topology evidence="16">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text evidence="16 34">Rapidly internalized after NGF binding (PubMed:1281417). Internalized to endosomes upon binding of NGF or NTF3 and further transported to the cell body via a retrograde axonal transport. Localized at cell membrane and early endosomes before nerve growth factor (NGF) stimulation. Recruited to late endosomes after NGF stimulation. Colocalized with RAPGEF2 at late endosomes.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P04629-1</id>
<name>TrkA-II</name>
<name>TrkAII</name>
<sequence type="displayed"/>
<text>Major isoform.</text>
</isoform>
<isoform>
<id>P04629-2</id>
<name>TrkA-I</name>
<name>TrkAI</name>
<sequence type="described" ref="VSP_002899"/>
<text>Has enhanced responsiveness to NTF3 neurotrophin.</text>
</isoform>
<isoform>
<id>P04629-3</id>
<name>3</name>
<sequence type="described" ref="VSP_041905 VSP_002899"/>
</isoform>
<isoform>
<id>P04629-4</id>
<name>TrkA-III</name>
<name>TrkAIII</name>
<sequence type="described" ref="VSP_042152 VSP_002899"/>
<text>Constitutively active. Does not bind NGF and does not interact with GRB2 and FRS2.</text>
</isoform>
<text>TrkA-I and TrkA-II isoforms have similar biological properties but are differentially expressed.</text>
</comment>
<comment type="tissue specificity">
<text evidence="36 50">Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors.</text>
</comment>
<comment type="induction">
<text evidence="36">Isoform TrkA-III is up-regulated upon hypoxia in cells normally expressing it.</text>
</comment>
<comment type="domain">
<text evidence="15">The transmembrane domain mediates interaction with KIDINS220.</text>
</comment>
<comment type="domain">
<text evidence="15">The extracellular domain mediates interaction with NGFR.</text>
</comment>
<comment type="PTM">
<text evidence="34 36 44 46 47 49 50">Ligand-mediated autophosphorylation (PubMed:2927393, PubMed:1281417, PubMed:15488758, PubMed:7510697, PubMed:8155326, PubMed:8325889, PubMed:27676246). Interaction with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at Tyr-496 mediates interaction and phosphorylation of SHC1 (PubMed:15488758, PubMed:7510697, PubMed:8155326, PubMed:8325889).</text>
</comment>
<comment type="PTM">
<text evidence="36 37 44 46">N-glycosylated (PubMed:2927393). Isoform TrkA-I and isoform TrkA-II are N-glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="17">Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor.</text>
</comment>
<comment type="disease" evidence="22 23 24 28 29 30 31 33 39 43 44 51">
<disease id="DI-01405">
<name>Congenital insensitivity to pain with anhidrosis</name>
<acronym>CIPA</acronym>
<description>Characterized by a congenital insensitivity to pain, anhidrosis (absence of sweating), absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation. This rare autosomal recessive disorder is also known as congenital sensory neuropathy with anhidrosis or hereditary sensory and autonomic neuropathy type IV or familial dysautonomia type II.</description>
<dbReference type="MIM" id="256800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="35 45 48">Chromosomal aberrations involving NTRK1 are found in papillary thyroid carcinomas (PTCs) (PubMed:2869410, PubMed:7565764, PubMed:1532241). Translocation t(1;3)(q21;q11) with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to the 3'-end of NTRK1 (PubMed:7565764). A rearrangement with TPM3 generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1 (PubMed:2869410). An intrachromosomal rearrangement that links the protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the C-terminus of the NTRK1 protein (PubMed:1532241).</text>
</comment>
<comment type="miscellaneous">
<text>Trk also stands for tropomyosin-related kinase since it was first isolated as an oncogenic protein which was the result of a fusion between the tropomyosin gene TPM3 and NTRK1.</text>
</comment>
<comment type="similarity">
<text evidence="20">Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="56">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="CAA27243" version="1"/>
</conflict>
<location>
<position position="786"/>
</location>
<text>Translated as Gln.</text>
</comment>
<comment type="sequence caution" evidence="56">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAA27243" version="1"/>
</conflict>
<location>
<position position="769"/>
</location>
</comment>
<comment type="sequence caution" evidence="56">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAA27243" version="1"/>
</conflict>
<text>Contaminating sequence. Sequence of unknown origin in the N-terminal part.</text>
</comment>
<comment type="sequence caution" evidence="56">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAA29888" version="1"/>
</conflict>
<text>Contaminating sequence. Sequence of unknown origin in the N-terminal part.</text>
</comment>
<comment type="sequence caution" evidence="56">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAA44719" version="1"/>
</conflict>
<text>Contaminating sequence. Sequence of unknown origin in the N-terminal part.</text>
</comment>
<comment type="sequence caution" evidence="56">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAA59936" version="1"/>
</conflict>
<text>Contaminating sequence. Sequence of unknown origin in the N-terminal part.</text>
</comment>
<dbReference type="EC" id="2.7.10.1" evidence="34 46"/>
<dbReference type="EMBL" id="M23102">
<property type="protein sequence ID" value="AAA36770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB019488">
<property type="protein sequence ID" value="BAA34355.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312704">
<property type="protein sequence ID" value="BAG35582.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DB265639">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158169">
<property type="protein sequence ID" value="CAH70010.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC062580">
<property type="protein sequence ID" value="AAH62580.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136554">
<property type="protein sequence ID" value="AAI36555.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC144239">
<property type="protein sequence ID" value="AAI44240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY321513">
<property type="protein sequence ID" value="AAP88292.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X03541">
<property type="protein sequence ID" value="CAA27243.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X06704">
<property type="protein sequence ID" value="CAA29888.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X85960">
<property type="protein sequence ID" value="CAA59936.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X62947">
<property type="protein sequence ID" value="CAA44719.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1161.1">
<molecule id="P04629-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30890.1">
<molecule id="P04629-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30891.1">
<molecule id="P04629-2"/>
</dbReference>
<dbReference type="PIR" id="A30124">
<property type="entry name" value="TVHUTT"/>
</dbReference>
<dbReference type="PIR" id="S23741">
<property type="entry name" value="S23741"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001007793.1">
<molecule id="P04629-3"/>
<property type="nucleotide sequence ID" value="NM_001007792.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012331.1">
<molecule id="P04629-2"/>
<property type="nucleotide sequence ID" value="NM_001012331.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002520.2">
<molecule id="P04629-1"/>
<property type="nucleotide sequence ID" value="NM_002529.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.406293"/>
<dbReference type="PDB" id="1HE7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=285-413"/>
</dbReference>
<dbReference type="PDB" id="1SHC">
<property type="method" value="NMR"/>
<property type="chains" value="B=489-500"/>
</dbReference>
<dbReference type="PDB" id="1WWA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="X/Y=278-386"/>
</dbReference>
<dbReference type="PDB" id="1WWW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="X/Y=282-382"/>
</dbReference>
<dbReference type="PDB" id="2IFG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=36-382"/>
</dbReference>
<dbReference type="PDB" id="2N90">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=410-447"/>
</dbReference>
<dbReference type="PDB" id="4AOJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/B/C=473-796"/>
</dbReference>
<dbReference type="PDB" id="4CRP">
<property type="method" value="NMR"/>
<property type="chains" value="A=282-383"/>
</dbReference>
<dbReference type="PDB" id="4F0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=498-796"/>
</dbReference>
<dbReference type="PDB" id="4GT5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=498-796"/>
</dbReference>
<dbReference type="PDB" id="4PMM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=501-787"/>
</dbReference>
<dbReference type="PDB" id="4PMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=501-787"/>
</dbReference>
<dbReference type="PDB" id="4PMS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=501-787"/>
</dbReference>
<dbReference type="PDB" id="4PMT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=501-787"/>
</dbReference>
<dbReference type="PDB" id="4YNE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=502-796"/>
</dbReference>
<dbReference type="PDB" id="4YPS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=502-796"/>
</dbReference>
<dbReference type="PDB" id="5H3Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=473-796"/>
</dbReference>
<dbReference type="PDB" id="5JFS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=502-796"/>
</dbReference>
<dbReference type="PDB" id="5JFV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="A=502-796"/>
</dbReference>
<dbReference type="PDB" id="5JFW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=502-796"/>
</dbReference>
<dbReference type="PDB" id="5JFX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A=502-796"/>
</dbReference>
<dbReference type="PDB" id="5KMI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDB" id="5KMJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.04"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDB" id="5KMK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.24"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDB" id="5KML">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDB" id="5KMM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDB" id="5KMN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.14"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDB" id="5KMO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.67"/>
<property type="chains" value="A=474-796"/>
</dbReference>
<dbReference type="PDBsum" id="1HE7"/>
<dbReference type="PDBsum" id="1SHC"/>
<dbReference type="PDBsum" id="1WWA"/>
<dbReference type="PDBsum" id="1WWW"/>
<dbReference type="PDBsum" id="2IFG"/>
<dbReference type="PDBsum" id="2N90"/>
<dbReference type="PDBsum" id="4AOJ"/>
<dbReference type="PDBsum" id="4CRP"/>
<dbReference type="PDBsum" id="4F0I"/>
<dbReference type="PDBsum" id="4GT5"/>
<dbReference type="PDBsum" id="4PMM"/>
<dbReference type="PDBsum" id="4PMP"/>
<dbReference type="PDBsum" id="4PMS"/>
<dbReference type="PDBsum" id="4PMT"/>
<dbReference type="PDBsum" id="4YNE"/>
<dbReference type="PDBsum" id="4YPS"/>
<dbReference type="PDBsum" id="5H3Q"/>
<dbReference type="PDBsum" id="5JFS"/>
<dbReference type="PDBsum" id="5JFV"/>
<dbReference type="PDBsum" id="5JFW"/>
<dbReference type="PDBsum" id="5JFX"/>
<dbReference type="PDBsum" id="5KMI"/>
<dbReference type="PDBsum" id="5KMJ"/>
<dbReference type="PDBsum" id="5KMK"/>
<dbReference type="PDBsum" id="5KML"/>
<dbReference type="PDBsum" id="5KMM"/>
<dbReference type="PDBsum" id="5KMN"/>
<dbReference type="PDBsum" id="5KMO"/>
<dbReference type="ProteinModelPortal" id="P04629"/>
<dbReference type="SMR" id="P04629"/>
<dbReference type="BioGrid" id="110969">
<property type="interactions" value="1942"/>
</dbReference>
<dbReference type="DIP" id="DIP-5714N"/>
<dbReference type="IntAct" id="P04629">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="MINT" id="MINT-124106"/>
<dbReference type="STRING" id="9606.ENSP00000431418"/>
<dbReference type="BindingDB" id="P04629"/>
<dbReference type="ChEMBL" id="CHEMBL2815"/>
<dbReference type="DrugBank" id="DB00321">
<property type="generic name" value="Amitriptyline"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1817"/>
<dbReference type="iPTMnet" id="P04629"/>
<dbReference type="PhosphoSitePlus" id="P04629"/>
<dbReference type="BioMuta" id="NTRK1"/>
<dbReference type="DMDM" id="94730402"/>
<dbReference type="PaxDb" id="P04629"/>
<dbReference type="PeptideAtlas" id="P04629"/>
<dbReference type="PRIDE" id="P04629"/>
<dbReference type="Ensembl" id="ENST00000368196">
<molecule id="P04629-2"/>
<property type="protein sequence ID" value="ENSP00000357179"/>
<property type="gene ID" value="ENSG00000198400"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392302">
<molecule id="P04629-3"/>
<property type="protein sequence ID" value="ENSP00000376120"/>
<property type="gene ID" value="ENSG00000198400"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000524377">
<molecule id="P04629-1"/>
<property type="protein sequence ID" value="ENSP00000431418"/>
<property type="gene ID" value="ENSG00000198400"/>
</dbReference>
<dbReference type="GeneID" id="4914"/>
<dbReference type="KEGG" id="hsa:4914"/>
<dbReference type="UCSC" id="uc001fqf.2">
<molecule id="P04629-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4914"/>
<dbReference type="DisGeNET" id="4914"/>
<dbReference type="GeneCards" id="NTRK1"/>
<dbReference type="GeneReviews" id="NTRK1"/>
<dbReference type="HGNC" id="HGNC:8031">
<property type="gene designation" value="NTRK1"/>
</dbReference>
<dbReference type="HPA" id="CAB004606"/>
<dbReference type="HPA" id="HPA035799"/>
<dbReference type="HPA" id="HPA076570"/>
<dbReference type="MalaCards" id="NTRK1"/>
<dbReference type="MIM" id="164970">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="191315">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="256800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04629"/>
<dbReference type="OpenTargets" id="ENSG00000198400"/>
<dbReference type="Orphanet" id="99361">
<property type="disease" value="Familial medullary thyroid carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="642">
<property type="disease" value="Hereditary sensory and autonomic neuropathy type 4"/>
</dbReference>
<dbReference type="Orphanet" id="64752">
<property type="disease" value="Hereditary sensory and autonomic neuropathy type 5"/>
</dbReference>
<dbReference type="Orphanet" id="146">
<property type="disease" value="Papillary or follicular thyroid carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31817"/>
<dbReference type="eggNOG" id="ENOG410IMMI">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XTGG">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118818"/>
<dbReference type="HOVERGEN" id="HBG056735"/>
<dbReference type="InParanoid" id="P04629"/>
<dbReference type="KO" id="K03176"/>
<dbReference type="OMA" id="KNVTCWA"/>
<dbReference type="OrthoDB" id="EOG091G01JY"/>
<dbReference type="PhylomeDB" id="P04629"/>
<dbReference type="TreeFam" id="TF106465"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167021">
<property type="pathway name" value="PLC-gamma1 signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167044">
<property type="pathway name" value="Signalling to RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-170968">
<property type="pathway name" value="Frs2-mediated activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-170984">
<property type="pathway name" value="ARMS-mediated activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-177504">
<property type="pathway name" value="Retrograde neurotrophin signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-187024">
<property type="pathway name" value="NGF-independant TRKA activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-187042">
<property type="pathway name" value="TRKA activation by NGF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-187706">
<property type="pathway name" value="Signalling to p38 via RIT and RIN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198203">
<property type="pathway name" value="PI3K/AKT activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198745">
<property type="pathway name" value="Signalling to STAT3"/>
</dbReference>
<dbReference type="SignaLink" id="P04629"/>
<dbReference type="SIGNOR" id="P04629"/>
<dbReference type="ChiTaRS" id="NTRK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04629"/>
<dbReference type="GenomeRNAi" id="4914"/>
<dbReference type="PRO" id="PR:P04629"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000198400"/>
<dbReference type="ExpressionAtlas" id="P04629">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04629">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031902">
<property type="term" value="C:late endosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005004">
<property type="term" value="F:GPI-linked ephrin receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048406">
<property type="term" value="F:nerve growth factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010465">
<property type="term" value="F:nerve growth factor receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043121">
<property type="term" value="F:neurotrophin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005166">
<property type="term" value="F:neurotrophin p75 receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000186">
<property type="term" value="P:activation of MAPKK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060385">
<property type="term" value="P:axonogenesis involved in innervation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061368">
<property type="term" value="P:behavioral response to formalin induced pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990090">
<property type="term" value="P:cellular response to nerve growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071316">
<property type="term" value="P:cellular response to nicotine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050966">
<property type="term" value="P:detection of mechanical stimulus involved in sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050965">
<property type="term" value="P:detection of temperature stimulus involved in sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042490">
<property type="term" value="P:mechanoreceptor differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007018">
<property type="term" value="P:microtubule-based movement"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038180">
<property type="term" value="P:nerve growth factor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048011">
<property type="term" value="P:neurotrophin TRK receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021553">
<property type="term" value="P:olfactory nerve development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043068">
<property type="term" value="P:positive regulation of programmed cell death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046579">
<property type="term" value="P:positive regulation of Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051965">
<property type="term" value="P:positive regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051968">
<property type="term" value="P:positive regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010623">
<property type="term" value="P:programmed cell death involved in cell development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014823">
<property type="term" value="P:response to activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048678">
<property type="term" value="P:response to axon injury"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051602">
<property type="term" value="P:response to electrical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051599">
<property type="term" value="P:response to hydrostatic pressure"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031667">
<property type="term" value="P:response to nutrient levels"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009314">
<property type="term" value="P:response to radiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060009">
<property type="term" value="P:Sertoli cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048485">
<property type="term" value="P:sympathetic nervous system development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000483">
<property type="entry name" value="Cys-rich_flank_reg_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="L_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR031635">
<property type="entry name" value="NTRK_C2"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR020461">
<property type="entry name" value="Tyr_kinase_neurotrophic_rcpt_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR020777">
<property type="entry name" value="Tyr_kinase_NGF_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR002011">
<property type="entry name" value="Tyr_kinase_rcpt_2_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF13855">
<property type="entry name" value="LRR_8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16920">
<property type="entry name" value="TPKR_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01939">
<property type="entry name" value="NTKRECEPTOR"/>
</dbReference>
<dbReference type="PRINTS" id="PR01940">
<property type="entry name" value="NTKRECEPTOR1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00082">
<property type="entry name" value="LRRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52058">
<property type="entry name" value="SSF52058"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00239">
<property type="entry name" value="RECEPTOR_TYR_KIN_II"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="18">
<location>
<begin position="1"/>
<end position="32"/>
</location>
</feature>
<feature type="chain" description="High affinity nerve growth factor receptor" id="PRO_0000016724">
<location>
<begin position="33"/>
<end position="796"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="18">
<location>
<begin position="33"/>
<end position="423"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="18">
<location>
<begin position="424"/>
<end position="439"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="18">
<location>
<begin position="440"/>
<end position="796"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="90"/>
<end position="113"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="116"/>
<end position="137"/>
</location>
</feature>
<feature type="domain" description="LRRCT">
<location>
<begin position="148"/>
<end position="193"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1" evidence="19">
<location>
<begin position="194"/>
<end position="283"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2" evidence="19">
<location>
<begin position="299"/>
<end position="365"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="20">
<location>
<begin position="510"/>
<end position="781"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="20">
<location>
<begin position="516"/>
<end position="524"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SQSTM1" evidence="15">
<location>
<begin position="469"/>
<end position="490"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="20 21">
<location>
<position position="650"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="20">
<location>
<position position="544"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form TRK and TRK-T3">
<location>
<begin position="398"/>
<end position="399"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form TRK-T1">
<location>
<position position="486"/>
</location>
</feature>
<feature type="site" description="Interaction with SHC1">
<location>
<position position="496"/>
</location>
</feature>
<feature type="site" description="Interaction with PLCG1">
<location>
<position position="791"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="36 44 49">
<location>
<position position="496"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="57">
<location>
<position position="676"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="36">
<location>
<position position="680"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="36">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="36 47 49">
<location>
<position position="791"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="67"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="95"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="121"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5 37">
<location>
<position position="188"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="202"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5 37">
<location>
<position position="262"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5 37">
<location>
<position position="281"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="318"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="323"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="338"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5 37">
<location>
<position position="358"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="401"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="36"/>
<end position="41"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="40"/>
<end position="50"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5 19 37">
<location>
<begin position="154"/>
<end position="191"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5 19 37">
<location>
<begin position="215"/>
<end position="265"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 3 4 5 7">
<location>
<begin position="300"/>
<end position="345"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041905" evidence="52">
<original>MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTEL</original>
<variation>MKEAALICLAPSVPPILTVKSWDTMQLRAARSRCTNLLAAS</variation>
<location>
<begin position="1"/>
<end position="71"/>
</location>
</feature>
<feature type="splice variant" description="In isoform TrkA-III." id="VSP_042152" evidence="56">
<original>GVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSF</original>
<variation>V</variation>
<location>
<begin position="192"/>
<end position="284"/>
</location>
</feature>
<feature type="splice variant" description="In isoform TrkA-I, isoform 3 and isoform TrkA-III." id="VSP_002899" evidence="52 53 54">
<location>
<begin position="393"/>
<end position="398"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201472270." id="VAR_068480" evidence="43">
<original>R</original>
<variation>W</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1007211." id="VAR_049714">
<original>G</original>
<variation>E</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55891455." id="VAR_041461" evidence="38">
<original>Q</original>
<variation>R</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs543320028." id="VAR_009623" evidence="24 31">
<original>R</original>
<variation>S</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells." id="VAR_009624" evidence="30 31">
<original>L</original>
<variation>P</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs540521894." id="VAR_041462" evidence="38">
<original>A</original>
<variation>V</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells; dbSNP:rs747711259." id="VAR_009625" evidence="24 31">
<original>L</original>
<variation>P</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55909005." id="VAR_041463" evidence="38">
<original>T</original>
<variation>M</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56000394." id="VAR_041464" evidence="38">
<original>V</original>
<variation>G</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35116695." id="VAR_041465" evidence="38">
<original>R</original>
<variation>G</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; dbSNP:rs121964869." id="VAR_068481" evidence="33">
<original>Y</original>
<variation>C</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56320207." id="VAR_041466" evidence="38">
<original>R</original>
<variation>Q</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34900547." id="VAR_041467" evidence="38">
<original>R</original>
<variation>C</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; dbSNP:rs144901788." id="VAR_068482" evidence="43">
<original>E</original>
<variation>K</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; following transfection in neuroblastoma cells and NGF treatment, small decrease in the percentage of cells differentiated into neuronal phenotype, but in differentiated cells, the average neurite length is comparable to wild-type; no effect on N-glycosylation, subcellular location, nor on basal and NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs606231467." id="VAR_077472" evidence="44">
<original>G</original>
<variation>E</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; no effect on N-glycosylation, nor on subcellular location; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux." id="VAR_077473" evidence="44">
<original>G</original>
<variation>E</variation>
<location>
<position position="522"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells." id="VAR_009626" evidence="30 31">
<original>G</original>
<variation>R</variation>
<location>
<position position="522"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55892037." id="VAR_041468" evidence="38">
<original>M</original>
<variation>T</variation>
<location>
<position position="566"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA." id="VAR_077474" evidence="39">
<original>I</original>
<variation>S</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; loss of function; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs121964866." id="VAR_004103" evidence="28 30 31 51">
<original>G</original>
<variation>R</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; dbSNP:rs121964870." id="VAR_009627" evidence="23">
<original>M</original>
<variation>V</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6336." id="VAR_009628" evidence="24 25 26 31 33 38">
<original>H</original>
<variation>Y</variation>
<location>
<position position="604"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6339." id="VAR_009629" evidence="24 25 26 29 31 33 38">
<original>G</original>
<variation>V</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs369353892." id="VAR_009630" evidence="24 31">
<original>R</original>
<variation>W</variation>
<location>
<position position="649"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs764992664." id="VAR_009631" evidence="30 31 43">
<original>R</original>
<variation>C</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; following transfection in neuroblastoma cells and NGF treatment, loss of differentiation into neuronal phenotype; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux." id="VAR_077475" evidence="44">
<original>L</original>
<variation>P</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; unknown pathological significance; might impair the function of the enzyme without compromising autophosphorylation; dbSNP:rs80356677." id="VAR_009632" evidence="30 31">
<original>D</original>
<variation>Y</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; dbSNP:rs121964868." id="VAR_009633" evidence="29">
<original>P</original>
<variation>L</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux." id="VAR_077476" evidence="44">
<original>I</original>
<variation>T</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs770727871." id="VAR_009634" evidence="24 31">
<original>G</original>
<variation>S</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; found in a compound heterozygote also carrying an premature stop codon at position 558." id="VAR_077477" evidence="39">
<original>L</original>
<variation>R</variation>
<location>
<position position="717"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; unknown pathological significance; following transfection in neuroblastoma cells and NGF treatment, no effect on neurite outgrowth, nor neurite length; no effect on N-glycosylation, subcellular location, basal and NGF-induced autophosphorylation, nor on NGF-stimulated calcium flux." id="VAR_077478" evidence="44">
<original>C</original>
<variation>S</variation>
<location>
<position position="752"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; following transfection in neuroblastoma cells and NGF treatment, decreased percentage of cells differentiated into neuronal phenotype and reduced neurite length compared with wild-type; slightly decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal and NGF-induced autophosphorylation; small reduction in NGF-stimulated calcium flux." id="VAR_077479" evidence="44">
<original>C</original>
<variation>S</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux." id="VAR_077480" evidence="44">
<original>R</original>
<variation>C</variation>
<location>
<position position="771"/>
</location>
</feature>
<feature type="sequence variant" description="In CIPA; loss of function; dbSNP:rs35669708." id="VAR_009635" evidence="22">
<original>R</original>
<variation>P</variation>
<location>
<position position="780"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35669708." id="VAR_009636" evidence="26 38">
<original>R</original>
<variation>Q</variation>
<location>
<position position="780"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55948542." id="VAR_041469" evidence="38">
<original>V</original>
<variation>I</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with SHC1 and altered phosphorylation of SHC1. Altered neurite outgrowth and altered activation of the MAPK pathway; when associated with F-791." evidence="49">
<original>Y</original>
<variation>F</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="34 49">
<original>K</original>
<variation>N</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PLCG1 and altered phosphorylation of PLCG1. Altered neurite outgrowth and altered activation of the MAPK pathway; when associated with F-496." evidence="47 49">
<original>Y</original>
<variation>F</variation>
<location>
<position position="791"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36770." ref="1" evidence="56">
<original>V</original>
<variation>L</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36770." ref="1" evidence="56">
<original>C</original>
<variation>S</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; CAA59936." ref="10" evidence="56">
<original>C</original>
<variation>S</variation>
<location>
<position position="529"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="43"/>
<end position="46"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="57"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="69"/>
<end position="72"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="94"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="110"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="157"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="178"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="195"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="211"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="227"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="234"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="244"/>
<end position="253"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="257"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="263"/>
<end position="265"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="284"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="298"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="326"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="342"/>
<end position="350"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="357"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="368"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="418"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="476"/>
<end position="478"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="490"/>
<end position="492"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="494"/>
<end position="496"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="507"/>
<end position="509"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="510"/>
<end position="517"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="524"/>
<end position="533"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="534"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="537"/>
<end position="545"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="552"/>
<end position="566"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="575"/>
<end position="579"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="581"/>
<end position="584"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="586"/>
<end position="590"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="597"/>
<end position="603"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="605"/>
<end position="607"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="608"/>
<end position="611"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="615"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="619"/>
<end position="621"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="624"/>
<end position="643"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="646"/>
<end position="648"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="653"/>
<end position="655"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="656"/>
<end position="659"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="660"/>
<end position="662"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="663"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="672"/>
<end position="675"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="677"/>
<end position="679"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="680"/>
<end position="683"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="684"/>
<end position="686"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="687"/>
<end position="689"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="691"/>
<end position="693"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="696"/>
<end position="701"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="706"/>
<end position="721"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="722"/>
<end position="724"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="727"/>
<end position="730"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="733"/>
<end position="742"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="754"/>
<end position="763"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="768"/>
<end position="770"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="774"/>
<end position="786"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="789"/>
<end position="793"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HE7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SHC"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WWA"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WWW"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IFG"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N90"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CRP"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4F0I"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PMP"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YNE"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JFV"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JFW"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KMI"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KML"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35739"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q3UFB7"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255"/>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10090906"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10233776"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10330344"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391209"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10443680"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10490030"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10567924"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10861667"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10982191"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11159935"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11244088"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11310631"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1281417"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1532241"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15488758"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17196528"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18077166"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1849459"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1850821"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21102451"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22302274"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27676246"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2869410"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2927393"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7510697"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7565764"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8155326"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8325889"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8696348"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2927393"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9290260"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000305"/>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8325889"/>
</source>
</evidence>
<sequence length="796" mass="87497" checksum="6C15C721E336B601" modified="2006-05-02" version="4" precursor="true">
MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLH
HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL
NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ
GPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMK
SGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWC
IPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYT
LLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSV
AVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTE
GKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKML
VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF
LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ
GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI
FTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR
LQALAQAPPVYLDVLG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>